IsoTis to Release Second Quarter 2007 Results on August 7

    IRVINE, CA, Aug. 3 /CNW/ - IsoTis, Inc. (NASDQ: ISOT), a leading
orthobiologics company, will release its 2007 second quarter results before
opening of trading on Tuesday, August 7, 2007.
    To discuss these results, the Company will conduct a conference call at
4:00 p.m. (Eastern Time)/1:00 p.m. (Pacific Time)/10:00 p.m. (Central European
Time). Dial in details will be provided in the Q2 2007 release on August 7,

    About the company:

    IsoTis is a leading orthobiologics company that develops, manufactures
and markets proprietary products for the treatment of musculoskeletal diseases
and disorders. IsoTis' current orthobiologics products are bone graft
substitutes that promote the regeneration of bone and are used to repair
natural, trauma-related and surgically-created defects common in orthopedic
procedures, including spinal fusions. IsoTis' current commercial business is
highlighted by its Accell line of products, which the company believes
represents the next generation in bone graft substitution.

For further information:

For further information: Rob Morocco, (949) 855-7155,; Hans Herklots, (949) 855-7195 or +41-21-620-6011,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890